| Product Code: ETC7539512 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India cell-based immunotherapy market import shipments experienced a declining trend from 2020 to 2024, with a compound annual growth rate of -1.7%. Notably, between 2023 and 2024, the growth rate decreased significantly by -25.5%, indicating a further slowdown in market expansion during that period. Overall, the market exhibited a deceleration in growth momentum and appeared to stabilize towards the end of the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cell-Based Immunotherapy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cell-Based Immunotherapy Market Revenues & Volume, 2021 & 2031F |
3.3 India Cell-Based Immunotherapy Market - Industry Life Cycle |
3.4 India Cell-Based Immunotherapy Market - Porter's Five Forces |
3.5 India Cell-Based Immunotherapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 India Cell-Based Immunotherapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Cell-Based Immunotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as cancer in India |
4.2.2 Growing investments in healthcare infrastructure and research development |
4.2.3 Rising awareness about personalized medicine and targeted therapies |
4.3 Market Restraints |
4.3.1 High cost associated with cell-based immunotherapy treatments |
4.3.2 Stringent regulatory requirements for cell-based therapies in India |
4.3.3 Limited availability of skilled professionals and specialized facilities for cell therapy production |
5 India Cell-Based Immunotherapy Market Trends |
6 India Cell-Based Immunotherapy Market, By Types |
6.1 India Cell-Based Immunotherapy Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 India Cell-Based Immunotherapy Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 India Cell-Based Immunotherapy Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.4 India Cell-Based Immunotherapy Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.5 India Cell-Based Immunotherapy Market Revenues & Volume, By Skin Cancer, 2021- 2031F |
6.1.6 India Cell-Based Immunotherapy Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.1.7 India Cell-Based Immunotherapy Market Revenues & Volume, By Brain Tumor, 2021- 2031F |
6.1.8 India Cell-Based Immunotherapy Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2 India Cell-Based Immunotherapy Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 India Cell-Based Immunotherapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 India Cell-Based Immunotherapy Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.2.4 India Cell-Based Immunotherapy Market Revenues & Volume, By Specialized Cancer Institutes, 2021- 2031F |
7 India Cell-Based Immunotherapy Market Import-Export Trade Statistics |
7.1 India Cell-Based Immunotherapy Market Export to Major Countries |
7.2 India Cell-Based Immunotherapy Market Imports from Major Countries |
8 India Cell-Based Immunotherapy Market Key Performance Indicators |
8.1 Patient enrollment in cell-based immunotherapy clinical trials |
8.2 Number of partnerships and collaborations between research institutions and pharmaceutical companies for cell therapy development |
8.3 Adoption rate of novel cell-based immunotherapy technologies in Indian healthcare facilities |
9 India Cell-Based Immunotherapy Market - Opportunity Assessment |
9.1 India Cell-Based Immunotherapy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 India Cell-Based Immunotherapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Cell-Based Immunotherapy Market - Competitive Landscape |
10.1 India Cell-Based Immunotherapy Market Revenue Share, By Companies, 2024 |
10.2 India Cell-Based Immunotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here